Company Pitch Presentations

Is your company a pioneer in cardiovascular tech innovation?

Showcase your groundbreaking solutions and boost your visibility at CTF 2024! Apply Here.

ImaCor – 2023 Judge’s Choice Award Recipient

Relief Cardio – 2023 People’s Choice Award Recipient

Apply to pitch for capital!

Are you a trailblazing company driving innovation in cardiovascular technology? Seize the opportunity to showcase your groundbreaking solutions and elevate your brand at Octane’s Cardiovascular Tech Forum 2024!

Octane is currently recruiting the best of the best innovative cardiovascular companies to join our event in the company presentation session on our main stage.  The session will feature the top five carefully selected and curated companies that will pitch for capital to our strategics including our longstanding partners such as Edwards Lifesciences, Johnson & Johnson, AbbVie, Medtronic, Masimo, and MicroVention, as well as industry experts, hospital systems including Hoag, Kaiser, UCI Health and CHOC, and investors.

The Forum presents two awards: the People’s Choice Award and the Judge’s Choice Award, featuring an American Heart Association Innovator Network Membership as the Grand Prize (valued at $25,000). 

Pitch your company to Octane’s ecosystem of high net worth angel investors and angel groups, family office, venture capitalists, strategics, and industry leaders at Octane’s Cardiovascular Tech Forum on September 13, 2024 at VEA Newport Beach.

Why Present at CTF 2024?

    Gain unparalleled exposure among industry leaders, investors, and healthcare professionals.
    Connect with potential collaborators, investors, and key decision-makers in the cardiovascular tech space.
    Demonstrate how your company is shaping the future of cardiovascular health through cutting-edge technologies.


How to Apply:

Complete the form to express your interest in presenting at the Cardiovascular Tech Forum 2024. Our Capital & Growth team will review and connect with you to discuss presentation opportunities.

2023 Octane Portfolio Presenting Companies


ImaCor has created the world’s first Precision Hemodynamics platform that combines imaging and monitoring in a portable package for ease-of-use by high acuity care teams. Building on our patented transesophageal ultrasound probe, ImaCor developed miniaturized hardware and AI-enabled software to establish this new Gold Standard for Precision Hemodynamics. Leading hospital systems have strongly supported our development, with focus on high acuity patients for whom the combination of imaging and monitoring is a lifesaving necessity.  ImaCor’s primary markets include Sepsis, Surgery, and Cardiac Support, reducing hospital costs, preserving revenue streams, and advancing Centers of Excellence. The markets are large, focused, and accessible.

Learn More.

Relief Cardiovascular

6 million Americans are living with heart failure, and nearly half a million experience at least three heart failure hospitalizations every year. These hospitalizations are primarily due to congestion and inadequate response to diuretic medication. To address this, Relief Cardiovascular is developing a closed-loop vascular implant for heart failure that integrates implantable sensors with a mechanism to enhance kidney perfusion. By providing an implantable automated method of volume management that doesn’t rely exclusively on diuretic medications, Relief aims to reduce the burden of heart failure for the millions of heart failure patients, caregivers, and the medical system.

Learn More.


Intra-Cardiac Echocardiography (ICE) catheters are used in Atrial Fibrillation and Ventricular Tachycardia procedures in the Electrocardiography (EP) market. ICE Catheters account for $1B of the $8B EP market and have double digit growth. There are currently just two players in the market. SoundCath developed the following MEMS based ICE catheter. 8Fr IceSite™ – 64 element 10Fr IceSite™ – 96 element 5Fr IceSite™ – 32 element Benefits of SoundCath’s ICE catheter versus traditional bulk PZT ICE Catheters: – High bandwidth resulting in superior image resolution and quality – Ultra-low cost – Miniaturize SoundCath will enter the US and Japan markets in 2024.

Learn More.

Stimcore Medical Devices

Stimcore LLC is a medical device company with an emphasis on airway, breathing and sleep, deploying diagnostic and therapeutic approaches. Its dedicated professionals are now initiating an innovative project based on the development/commercialization of smart, wearable devices that address rhino-sinusitis, sleep disordered breathing and obstructive sleep apnea. The company has secure intellectual property, with new patent submissions in the pipeline, as well as exclusive licensing deals. Stimcore’s suite of novel devices harness exclusive biosignaling pathways and a portfolio of unique clinical protocols, based on bioengineering excellence for new product development, aimed at pre-existing and new billing codes after FDA acceptance.

The Company’s FlexPoint® steerable transseptal needle, is already cleared for marketing in the US (Class II) and Europe (CE Mark).  This is the only known steerable needle in existence and targets a worldwide market of over 350,000 units annually, and growing.  The device has been used in over 1,000 clinical cases.

Learn More.

Total Flow Medical

Total Flow Medical’s mission is to improve the length and quality of life for heart surgery and life support patients. Our first product is a cannula for cardiopulmonary bypass, used during minimally invasive heart surgery. Costing the US healthcare system an estimate $1B per year, standard cannula can block blood flow in patients’ legs- leading to ischemic limb conditions, amputation and even death. With our patented solutions, we plan to become the standard of care in femoral cannulation to treat the 100k US patients per year. Designed by clinicians, our easy-to-use solutions do not interrupt clinical workflow and help surgeons to take care of their patients’ limbs and lives.

Learn More.

2023 Judges

Haleh Armian, MSc
Director of Biomedical Innovation Ventures, Hoag
Duncan Fatkin
Chief Commercial Officer,
Beyond Air Inc.

Virginia Giddings, PhD
Vice President of Exploration,
Edwards Lifesciences

OC Innovation Week: Opening Reception

UCI Beall Applied Innovation 5270 California Ave # 100, Irvine, CA

Join us for the grand kickoff of OC Innovation Week at our Opening Reception, where excitement and innovation converge.

Fast Pitch

The Cove at UCI Applied Innovation 5270 California Ave, Irvine, CA, United States

Fast Pitch is a unique opportunity for Orange County's tech innovators to showcase their groundbreaking ideas. Participants present their pitches to a distinguished panel of judges, potential partners, and investors.

Contact Us


4041 MacArthur Blvd, Suite 260 Newport Beach, CA 92660


© 2024 Octane